The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'?

被引:512
作者
Whiteman, M
Armstrong, JS
Chu, SH
Jia-Ling, S
Wong, BS
Cheung, NS
Halliwell, B
Moore, PK
机构
[1] Natl Univ Singapore, Fac Med, Dept Biochem, Singapore 117597, Singapore
[2] Natl Univ Singapore, Fac Med, Dept Pharmacol, Singapore 117597, Singapore
关键词
3-nitrotyrosine; hydrogen sulfide; neurodegeneration; nitrosative stress; oxidative stress; peroxynitrite;
D O I
10.1111/j.1471-4159.2004.02617.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogen sulfide (H2S) is a well-known cytotoxic gas. Recently it has been shown to stimulate N-methyl-D-aspartate (NMDA) receptors to enhance long-term potentiation suggesting a novel neuromodulatory role in vivo. Endogenous levels of H2S in the brain are reported to range between 10 and 160 mum. Considerably lower H2S levels are reported in the brains of Alzheimer's disease (AD) patients, where levels of brain protein nitration (probably mediated by peroxynitrite) are markedly increased. Activation of NMDA receptors leads to intracellular tyrosine nitration by peroxynitrite. Because H2S and peroxynitrite are important mediators in brain function and disease, we investigated the effects of the H2S 'donor', sodium hydrogen sulfide (NaSH) on peroxynitrite-mediated damage to biomolecules and to cultured human SH-SY5Y cells. H2S significantly inhibited peroxynitrite-mediated tyrosine nitration and inactivation of alpha(1)-antiproteinase to a similar extent to reduced glutathione at each concentration tested (30-250 mum). H2S also inhibited peroxynitrite-induced cytotoxicity, intracellular protein nitration and protein oxidation in human neuroblastoma SH-SY5Y cells. These data suggest that H2S has the potential to act as an inhibitor of peroxynitrite-mediated processes in vivo and that the potential antioxidant action of H2S deserves further study, given that extracellular GSH levels in the brain are very low.
引用
收藏
页码:765 / 768
页数:4
相关论文
共 43 条
[1]  
Abe K, 1996, J NEUROSCI, V16, P1066
[2]   Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children [J].
Bayir, H ;
Kagan, VE ;
Tyurina, YY ;
Tyurin, V ;
Ruppel, RA ;
Adelson, PD ;
Graham, SH ;
Janesko, K ;
Clark, RSB ;
Kochanek, PM .
PEDIATRIC RESEARCH, 2002, 51 (05) :571-578
[3]   Oxidatively modified proteins in aging and disease [J].
Beal, MF .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (09) :797-803
[4]   Oxidative damage and tyrosine nitration from peroxynitrite [J].
Beckman, JS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (05) :836-844
[5]  
BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229
[6]  
Browne SE, 1999, BRAIN PATHOL, V9, P147
[7]  
BUSS H, 1997, FREE RADICAL BIO MED, V23, P631
[8]   Proteomics for the identification of specifically oxidized proteins in brain: Technology and application to the study of neurodegenerative disorders [J].
Butterfield, DA ;
Castegna, A .
AMINO ACIDS, 2003, 25 (3-4) :419-425
[9]   Proteomic identification of nitrated proteins in Alzheimer's disease brain [J].
Castegna, A ;
Thongboonkerd, V ;
Klein, JB ;
Lynn, B ;
Markesbery, WR ;
Butterfield, DA .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 (06) :1394-1401
[10]   The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence [J].
Danysz, W ;
Parsons, CG .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 :S23-S32